FDA Drug Recalls

Recalls / Class II

Class IID-0715-2023

Product

PHENYLephrine added to 0.9% sodium chloride, 10 mg/250 mL* (40 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-6058-1.

Affected lot / code info
Lot # 37-884272, Exp 05/03/2023; 37-887513, Exp 05/16/2023; 37-888083, Exp 05/18/2023; 37-889123, 37-889423, Exp 05/23/2023; 37-891563, Exp 06/01/2023; 37-892577, 37-892582, Exp 06/06/2023; 37-893248, 37-893257, Exp 06/08/2023; 37-894436, Exp 06/13/2023; 37-895805, Exp 06/19/2023; 37-898324, Exp 06/28/2023

Why it was recalled

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Recalling firm

Firm
Central Admixture Pharmacy Services, Inc.
Notification channel
E-Mail
Type
Voluntary: Firm initiated
Address
6580 Snowdrift Rd Ste 100, N/A, Allentown, Pennsylvania 18106-9331

Distribution

Quantity
6407 bags
Distribution pattern
Nationwide in the USA.

Timeline

Recall initiated
2023-04-28
FDA classified
2023-05-19
Posted by FDA
2023-05-31
Terminated
2025-06-22
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0715-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls